Literature DB >> 17516988

Delayed protection of tetramethylpyrazine on neonatal rat cardiomyocytes subjected to anoxia-reoxygenation injury.

He-Ping Chen1, Ming He, Qi-Ren Huang, Guo-Hua Zeng, Dan Liu.   

Abstract

The aim of this study was to investigate the cardioprotective effects and the possible mechanisms of delayed preconditioning induced by tetramethylpyrazine (TMP) in cultured neonatal rat cardiomyocytes subjected to anoxia-reoxygenation injury. Cultured neonatal rat cardiomyocytes were preconditioned using TMP at different concentrations (100, 200 and 500 microM). Cell viability, lactate dehydrogenase release, malondialdehyde formation, superoxide dismutase activity and glutathione peroxidase activity were measured to determine the protective effects against anoxia-reoxygenation injury. The expression of heat shock protein 70 (Hsp70) was measured 24 hr after TMP preconditioning by Western blot analysis. The results showed that TMP decreased lactate dehydrogenase release, increased cell viability, suppressed malondialdehyde formation and augmented activities of superoxide dismutase and glutathione peroxidase in a concentration-dependent manner. Moreover, the delayed protection was abolished by pre-treating with either protein kinase C inhibitor chelerythrine chloride or PD98059, a selective inhibitor of extracellular signal-regulated protein kinase 1/2, respectively, and the expression of Hsp70 was significantly increased in 24 hr after TMP preconditioning that was also suppressed by chelerythrine chloride or PD98059. These results suggest that TMP can induce delayed cardioprotective effects by activation of protein kinase C and extracellular signal-regulated protein kinase 1/2 signalling pathways and subsequent increased expression of Hsp70 in rat neonatal cardiomyocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17516988     DOI: 10.1111/j.1742-7843.2007.00059.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  4 in total

1.  Inhibitory effect of tetramethylpyrazine preconditioning on overload training-induced myocardial apoptosis in rats.

Authors:  Yi Yang; Zhang-Hua Li; Hua Liu; Wu-di Shi; Jie Zhang
Journal:  Chin J Integr Med       Date:  2014-05-10       Impact factor: 1.978

Review 2.  Protective effect of tetramethylpyrazine on myocardial ischemia-reperfusion injury.

Authors:  Weidong Qian; Xingjiang Xiong; Zhuyuan Fang; Haiting Lu; Zhensheng Wang
Journal:  Evid Based Complement Alternat Med       Date:  2014-07-24       Impact factor: 2.629

3.  Tetramethylpyrazine reverses high-glucose induced hypoxic effects by negatively regulating HIF-1α induced BNIP3 expression to ameliorate H9c2 cardiomyoblast apoptosis.

Authors:  Qiaowen Li; Chih-Yang Huang; Shih-Ping Liu; Marthandam Asokan Shibu; Fuu-Jen Tsai; Yuan-Man Hsu; Chang-Hai Tsai; Jing-Gung Chung; Jai-Sing Yang; Chih-Hsin Tang; Shulin Wang
Journal:  Nutr Metab (Lond)       Date:  2020-01-31       Impact factor: 4.169

4.  Tetramethylpyrazine Attenuates the Endotheliotoxicity and the Mitochondrial Dysfunction by Doxorubicin via 14-3-3γ/Bcl-2.

Authors:  Bin Yang; Hongwei Li; Yang Qiao; Qing Zhou; Shuping Chen; Dong Yin; Huan He; Ming He
Journal:  Oxid Med Cell Longev       Date:  2019-12-03       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.